Concepedia

Shabana Ather

SA

6

Publications

522

Citations

6

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Inserm

University of California, San Francisco

MSD K.K. (Japan)

University of Southern Denmark

Shabana Ather is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in anabolic steroids, medicine, and pharmacotherapy.

Top concepts

Publications per year

2004–2019

6

Publications

6

A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

Dimitris A. Papanicolaou, Shabana Ather, Hao Zhu et al. · The journal of nutrition health & aging · 2013 · 186 citations · Full text

, , +11

Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial

Kim Brixen, Roland Chapurlat, Angela M. Cheung et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 122 citations · Full text

Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study

Bruce E. Sands, Brian G. Feagan, William J. Sandborn et al. · The American Journal of Gastroenterology · 2019 · 83 citations · Full text

Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength

Angela M. Cheung, Sharmila Majumdar, Kim Brixen et al. · Journal of Bone and Mineral Research · 2014 · 69 citations · Full text

Odanacatib Treatment Affects Trabecular and Cortical Bone in the Femur of Postmenopausal Women: Results of a Two-Year Placebo-Controlled Trial

Klaus Engelke, Thomas Fuerst, Bernard J. Dardzinski et al. · Journal of Bone and Mineral Research · 2014 · 45 citations · Full text

Rows per page

1–5 of 6